• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经疾病的检测、预后和治疗评估的生物标志物。

Biomarkers for detection, prognosis and therapeutic assessment of neurological disorders.

机构信息

Distinguished Scientist Laboratory, Biotech Park, Sector-G Jankipram, Kursi Road, Lucknow 226021, Uttar Pradesh, India.

Distinguished Scientist Laboratory, Biotech Park, Lucknow 226021, Uttar Pradesh, India.

出版信息

Rev Neurosci. 2018 Sep 25;29(7):771-789. doi: 10.1515/revneuro-2017-0097.

DOI:10.1515/revneuro-2017-0097
PMID:29466244
Abstract

Neurological disorders have aroused a significant concern among the health scientists globally, as diseases such as Parkinson's, Alzheimer's and dementia lead to disability and people have to live with them throughout the life. Recent evidence suggests that a number of environmental chemicals such as pesticides (paraquat) and metals (lead and aluminum) are also the cause of these diseases and other neurological disorders. Biomarkers can help in detecting the disorder at the preclinical stage, progression of the disease and key metabolomic alterations permitting identification of potential targets for intervention. A number of biomarkers have been proposed for some neurological disorders based on laboratory and clinical studies. In silico approaches have also been used by some investigators. Yet the ideal biomarker, which can help in early detection and follow-up on treatment and identifying the susceptible populations, is not available. An attempt has therefore been made to review the recent advancements of in silico approaches for discovery of biomarkers and their validation. In silico techniques implemented with multi-omics approaches have potential to provide a fast and accurate approach to identify novel biomarkers.

摘要

神经紊乱疾病已引起全球健康科学家的高度关注,因为帕金森病、阿尔茨海默病和痴呆等疾病会导致残疾,人们必须终生与之共存。最近的证据表明,一些环境化学物质,如杀虫剂(百草枯)和金属(铅和铝),也是这些疾病和其他神经紊乱疾病的病因。生物标志物可帮助在临床前阶段、疾病进展和关键代谢组学改变中检测到该疾病,从而确定潜在的干预目标。一些生物标志物已经基于实验室和临床研究在一些神经紊乱疾病中被提出。一些研究人员也使用了计算方法。然而,目前还没有能够帮助早期检测、治疗随访和识别易感人群的理想生物标志物。因此,尝试对计算方法在生物标志物发现和验证方面的最新进展进行综述。结合多组学方法的计算技术具有提供快速、准确识别新型生物标志物的潜力。

相似文献

1
Biomarkers for detection, prognosis and therapeutic assessment of neurological disorders.神经疾病的检测、预后和治疗评估的生物标志物。
Rev Neurosci. 2018 Sep 25;29(7):771-789. doi: 10.1515/revneuro-2017-0097.
2
Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders.用于急性和慢性神经障碍的神经病理学和治疗干预的渐进性评估的实验和临床生物标志物。
Int J Mol Sci. 2022 Oct 3;23(19):11734. doi: 10.3390/ijms231911734.
3
4
Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.不同神经疾病的常见基因网络特征及其对神经艾滋病的潜在影响。
PLoS One. 2017 Aug 8;12(8):e0181642. doi: 10.1371/journal.pone.0181642. eCollection 2017.
5
Chemical & biological therapeutic approaches to neurological disorders.针对神经疾病的化学与生物治疗方法。
Drug News Perspect. 2010 Oct;23(8):524-31. doi: 10.1358/dnp.2010.23.8.1524353.
6
Recent advances in metabolomics in neurological disease, and future perspectives.神经疾病代谢组学的最新进展和未来展望。
Anal Bioanal Chem. 2013 Oct;405(25):8143-50. doi: 10.1007/s00216-013-7061-4. Epub 2013 May 30.
7
MicroRNAs as promising novel biomarkers and potential drug targets for inflammatory neurological diseases.微小RNA作为炎症性神经疾病有前景的新型生物标志物和潜在药物靶点。
J Neurol Sci. 2015 Sep 15;356(1-2):3-4. doi: 10.1016/j.jns.2015.06.023. Epub 2015 Jun 14.
8
Biomarkers: Role and Scope in Neurological Disorders.生物标志物:在神经紊乱中的作用和范围。
Neurochem Res. 2023 Jul;48(7):2029-2058. doi: 10.1007/s11064-023-03873-4. Epub 2023 Feb 16.
9
Is telomere length a biomarker of neurological disorders?端粒长度是否是神经紊乱的生物标志物?
Biomark Med. 2017 Sep;11(9):799-810. doi: 10.2217/bmm-2017-0032.
10
MicroRNAs in Neurodegenerative Diseases.神经退行性疾病中的微小RNA
Int Rev Cell Mol Biol. 2017;334:309-343. doi: 10.1016/bs.ircmb.2017.04.002. Epub 2017 Jun 16.

引用本文的文献

1
Transcriptome Derived Artificial neural networks predict PRRC2A as a potent biomarker for epilepsy.转录组衍生的人工神经网络预测PRRC2A作为癫痫的一种有效生物标志物。
J Genet Eng Biotechnol. 2025 Jun;23(2):100503. doi: 10.1016/j.jgeb.2025.100503. Epub 2025 May 12.
2
Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives.使用各种抗凝添加剂采集的血浆、血清和全血的全球生化分析。
PLoS One. 2021 Apr 8;16(4):e0249797. doi: 10.1371/journal.pone.0249797. eCollection 2021.
3
The Protective Effect of DiDang Tang Against AlCl-Induced Oxidative Stress and Apoptosis in PC12 Cells Through the Activation of SIRT1-Mediated Akt/Nrf2/HO-1 Pathway.
抵挡汤通过激活SIRT1介导的Akt/Nrf2/HO-1通路对氯化铝诱导的PC12细胞氧化应激和凋亡的保护作用
Front Pharmacol. 2020 Apr 15;11:466. doi: 10.3389/fphar.2020.00466. eCollection 2020.
4
Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values.应激相关疾病/障碍中的生物标志物:诊断、预后及治疗价值
Front Mol Biosci. 2019 Oct 18;6:91. doi: 10.3389/fmolb.2019.00091. eCollection 2019.